Actively Recruiting
Observational Study of ET-SPACE Whole-Body Infrared Hyperthermia Impact on Metabolism, Immune Function, and Palliative Outcomes in Advanced Solid Tumors
Led by Zhejiang Hospital · Updated on 2026-08-28
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the biological changes, palliative effects, and safety related to ET-SPACE whole-body infrared hyperthermia in patients with advanced solid tumors. This observational study includes patients who received this noninvasive treatment, which uses infrared energy to gently raise body temperature. Participants treated between January 1, 2022, and December 31, 2028, will be studied retrospectively through medical records or followed prospectively. The study collects detailed information on patient and tumor characteristics, laboratory results, treatments including hyperthermia and other anticancer or supportive therapies, adverse events, and outcomes. Data on metabolism, immune and inflammatory responses, nutritional status, quality of life, cancer pain, functional ability, symptom burden, and tumor-specific palliative scores are assessed before and after hyperthermia. Treatment is given as part of routine care and is not assigned by the study. Participants will have assessments including nutritional indexes, cancer pain intensity, quality of life questionnaires, symptom evaluations, performance status, immune-inflammation markers, and T-cell ratios at baseline and follow-up weeks. Safety is monitored for hyperthermia-related adverse events up to 16 weeks. Tumor response, disease control, progression-free survival, and overall survival are also tracked for up to 12 months to understand the potential supportive role of this therapy in advanced solid tumors.
CONDITIONS
Brief Title
ET-SPACE Whole-Body Infrared Hyperthermia in Patients With Advanced Solid Tumors
Research Team
P
Pengyuan Liu, Dr.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here